StockNews.AI
MGRM
StockNews.AI
160 days

CORRECTION: Monogram Technologies Reports Full Year 2024 Financial Results

1. MGRM corrected its financial tables and submitted a formal FDA response. 2. Management will host a business update call on March 12, 2025.

2m saved
Insight
Article

FAQ

Why Bullish?

Correcting financial statements positively reflects on company transparency; effective FDA engagement increases compliance confidence.

How important is it?

Financial corrections and FDA compliance are pivotal for MGRM's market credibility and growth prospects.

Why Short Term?

Upcoming business update call will likely influence investor sentiment shortly.

Related Companies

MDXGHOLXTMCI
This Press Release is Acting as a Correction to the Financial Tables in the Previous Release Completed all Supplemental Testing and has Submitted its Formal Response to the FDA's Additional Information Request (AIR) Management to Host Business Update Conference Call on Wednesday, March 12, 2025, at 4:30 p.m. Eastern Time AUSTIN, TEXAS / ACCESS Newswire / March 12, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, has reported its financial and operational results for the fourth quarter and year ended December 31, 2024.

Related News